Both in Biotechnology
TScan Therapeutics vs Acumen Pharmaceuticals
Over the past year TCRX returned −81.3% and ABOS returned −88.9%; their daily moves had a correlation of 0.13.
TCRX −81.3% ABOS −88.9%Growth of $1, one year, split-adjusted
| Metric | TCRX | ABOS |
|---|---|---|
| Price | $0.2100 | $0.2163 |
| Market cap | $14.2M | $15.6M |
| Today | +11.11% | −7.72% |
| 1 month | −23.7% | −89.3% |
| 6 months | −83.2% | −91.6% |
| Year to date | −79.0% | −89.7% |
| 1 year | −83.1% | −90.1% |
| Revenue growth (YoY) | −65.8% | — |
| Gross margin | 100.0% | — |
| Net margin | −2888.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.0× | — |
| Net cash | $67.4M | $52.3M |
| Dividend yield | — | — |
| Volatility (60d) | 143.0% | 492.9% |
| Short % of float | 4.1% | 7.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).